Cleared Traditional

K020543 - OHMEDA MEDICAL GIRAFFE OMNIBED

K020543 is the FDA 510(k) clearance for OHMEDA MEDICAL GIRAFFE OMNIBED by Ohmeda Medical. It is a Class 2 General Hospital device (product code FMZ) cleared through the Traditional 510(k) pathway after a 79-day FDA review.

K020543 · Ohmeda Medical · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2002
Decision
79d
Days
Class 2
Risk

K020543 is an FDA 510(k) clearance for the OHMEDA MEDICAL GIRAFFE OMNIBED. Classified as Incubator, Neonatal (product code FMZ), Class II - Special Controls.

Submitted by Ohmeda Medical (Laurel, US). The FDA issued a Cleared decision on May 9, 2002 after a review of 79 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5400 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ohmeda Medical devices

Submission Details

510(k) Number K020543 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 19, 2002
Decision Date May 09, 2002
Days to Decision 79 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
50d faster than avg
Panel avg: 129d · This submission: 79d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FMZ Incubator, Neonatal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMZ Incubator, Neonatal

All 32
Devices cleared under the same product code (FMZ) and FDA review panel - the closest regulatory comparables to K020543.
MODIFICATION TO: OHMEDA MEDICAL GIRAFFE INCUBATOR (GIRAFFE AND PANDA UNINTERRUPTIBLE POWER SUPPLY)
K072512 · Datex-Ohmeda, Inc. · Oct 2007
OHMEDA MEDICAL GIRAFFE OMNIBED
K071175 · Ge Healthcare · Jul 2007
BILIBLANKET PLUS HIGH OUTPUT PHOTOTHERAPY SYSTEM
K040068 · Ohmeda Medical · Apr 2004
OHMEDA MEDICAL GIRAFFE INCUBATOR
K020547 · Ohmeda Medical · May 2002
OHMEDA MEDICAL GIRAFFE INCUBATOR
K010222 · Ohmeda Medical · Mar 2001
OHMEDA MEDICAL OMNIBED
K993407 · Ohmeda Medical · Jan 2000